Citadel Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $944K | Buy |
105,400
+91,500
| +658% | +$729K | ﹤0.01% | 7790 |
|
|
2025
Q4 | $83.8K | Sell |
13,900
-2,000
| -13% | -$11.9K | ﹤0.01% | 11766 |
|
|
2025
Q3 | $90.8K | Sell |
15,900
-12,800
| -45% | -$65.5K | ﹤0.01% | 11902 |
|
|
2025
Q2 | $145K | Sell |
28,700
-2,200
| -7% | -$11.8K | ﹤0.01% | 10995 |
|
|
2025
Q1 | $200K | Buy |
30,900
+2,300
| +8% | +$20.4K | ﹤0.01% | 10444 |
|
|
2024
Q4 | $210K | Buy |
28,600
+19,000
| +198% | +$150K | ﹤0.01% | 10369 |
|
|
2024
Q3 | $71.9K | Sell |
9,600
-11,200
| -54% | -$97.3K | ﹤0.01% | 11521 |
|
|
2024
Q2 | $185K | Sell |
20,800
-3,200
| -13% | -$30.7K | ﹤0.01% | 10053 |
|
|
2024
Q1 | $243K | Buy |
24,000
+6,600
| +38% | +$67.2K | ﹤0.01% | 9915 |
|
|
2023
Q4 | $175K | Sell |
17,400
-4,000
| -19% | -$36.5K | ﹤0.01% | 10144 |
|
|
2023
Q3 | $201K | Sell |
21,400
-33,600
| -61% | -$479K | ﹤0.01% | 9903 |
|
|
2023
Q2 | $1.35M | Buy |
55,000
+27,100
| +97% | +$681K | ﹤0.01% | 5874 |
|
|
2023
Q1 | $649K | Buy |
27,900
+22,000
| +373% | +$563K | ﹤0.01% | 7751 |
|
|
2022
Q4 | $149K | Sell |
5,900
-21,500
| -78% | -$527K | ﹤0.01% | 10613 |
|
|
2022
Q3 | $528K | Sell |
27,400
-19,600
| -42% | -$498K | ﹤0.01% | 8339 |
|
|
2022
Q2 | $1.2M | Sell |
47,000
-14,900
| -24% | -$348K | ﹤0.01% | 6613 |
|
|
2022
Q1 | $1.59M | Sell |
61,900
-40,100
| -39% | -$1.19M | ﹤0.01% | 6602 |
|
|
2021
Q4 | $4.27M | Buy |
102,000
+34,200
| +50% | +$1.34M | ﹤0.01% | 4617 |
|
|
2021
Q3 | $2.95M | Buy |
67,800
+12,900
| +23% | +$558K | ﹤0.01% | 5399 |
|
|
2021
Q2 | $2.6M | Sell |
54,900
-37,000
| -40% | -$1.68M | ﹤0.01% | 5941 |
|
|
2021
Q1 | $4.71M | Buy |
91,900
+56,100
| +157% | +$3.02M | ﹤0.01% | 4381 |
|
|
2020
Q4 | $959K | Buy |
35,800
+10,500
| +42% | +$341K | ﹤0.01% | 6883 |
|
|
2020
Q3 | $869K | Buy |
25,300
+5,000
| +25% | +$215K | ﹤0.01% | 6281 |
|
|
2020
Q2 | $832K | Buy |
+20,300
| New | +$681K | ﹤0.01% | 6174 |
|
Other funds holding VIR
AVM
SIAU
VPM
GP
VCM
ACM